Study title: Becker muscular dystrophy associated with focal myositis on bone scintigraphy. Minshew PT, Silverman ED, Samuels-Botts C. Clin Nucl Med. 2000 Dec;25(12):1010-2.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Diagnosis [E01] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: TECHNETIUM (99mTc) MEDRONIC ACID | |||||
ATC code: V09BA02 | |||||
Document link: | |||||
Document date: 2014-12-08 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |